Skip to content

Calsyntenin-3 (CLSTN3)

Homo sapiens — UniProt Q9BQT9

Gene: CLSTN3Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Calsyntenin-3 (CLSTN3) is a protein from Homo sapiens identified by UniProt accession Q9BQT9, 956 residues long. MolForge cross-references it against 0 known binders and 92 disease associations.

  • UniProt accession: Q9BQT9; gene symbol CLSTN3.
  • Organism: Homo sapiens.
  • Length: 956 amino acids.
  • Top disease associations (Open Targets): autism spectrum disorder, neurodegenerative disease and blood protein measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameCalsyntenin-3
UniProt accessionQ9BQT9
GeneCLSTN3
OrganismHomo sapiens
Length956 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (92)

Diseases linked to this target (Open Targets).

  • autism spectrum disorder · score 0.33
  • neurodegenerative disease · score 0.29
  • blood protein measurement · score 0.19
  • total blood protein measurement · score 0.18
  • platelet crit · score 0.13
  • complement C1s subcomponent measurement · score 0.09
  • Young adult-onset Parkinsonism · score 0.05
  • platelet count · score 0.05
  • Spinocerebellar ataxia type 40 · score 0.05
  • spinocerebellar ataxia type 20 · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9BQT9-F1alphafoldPREDICTED77.25—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9BQT9.

Amino-acid sequence (956 residues)

MTLLLLPLLL ASLLASCSCN KANKHKPWIE AEYQGIVMEN DNTVLLNPPL FALDKDAPLR YAGEICGFRL HGSGVPFEAV ILDKATGEGL IRAKEPVDCE AQKEHTFTIQ AYDCGEGPDG ANTKKSHKAT VHVRVNDVNE FAPVFVERLY RAAVTEGKLY DRILRVEAID GDCSPQYSQI CYYEILTPNT PFLIDNDGNI ENTEKLQYSG ERLYKFTVTA YDCGKKRAAD DAEVEIQVKP TCKPSWQGWN KRIEYAPGAG SLALFPGIRL ETCDEPLWNI QATIELQTSH VAKGCDRDNY SERALRKLCG AATGEVDLLP MPGPNANWTA GLSVHYSQDS SLIYWFNGTQ AVQVPLGGPS GLGSGPQDSL SDHFTLSFWM KHGVTPNKGK KEEETIVCNT VQNEDGFSHY SLTVHGCRIA FLYWPLLESA RPVKFLWKLE QVCDDEWHHY ALNLEFPTVT LYTDGISFDP ALIHDNGLIH PPRREPALMI GACWTEEKNK EKEKGDNSTD TTQGDPLSIH HYFHGYLAGF SVRSGRLESR EVIECLYACR EGLDYRDFES LGKGMKVHVN PSQSLLTLEG DDVETFNHAL QHVAYMNTLR FATPGVRPLR LTTAVKCFSE ESCVSIPEVE GYVVVLQPDA PQILLSGTAH FARPAVDFEG TNGVPLFPDL QITCSISHQV EAKKDESWQG TVTDTRMSDE IVHNLDGCEI SLVGDDLDPE RESLLLDTTS LQQRGLELTN TSAYLTIAGV ESITVYEEIL RQARYRLRHG AALYTRKFRL SCSEMNGRYS SNEFIVEVNV LHSMNRVAHP SHVLSSQQFL HRGHQPPPEM AGHSLASSHR NSMIPSAATL IIVVCVGFLV LMVVLGLVRI HSLHRRVSGA GGPPGASSDP KDPDLFWDDS ALTIIVNPME SYQNRQSCVT GAVGGQQEDE DSSDSEVADS PSSDERRIIE TPPHRY

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with CLSTN3?

The strongest Open Targets associations for CLSTN3 are autism spectrum disorder, neurodegenerative disease, blood protein measurement, total blood protein measurement and platelet crit.

How long is the CLSTN3 protein?

The Homo sapiens CLSTN3 protein (UniProt Q9BQT9) is 956 amino acids long.

Browse: Targets: C · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Calsyntenin-3 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9BQT9
GeneCLSTN3
OrganismHomo sapiens
Length956
Binders0
Diseases92
View on UniProt